Ondine Biomedical Inc.
OBIMF
$0.14
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.74% | -16.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.74% | -16.98% | |||
| Cost of Revenue | 3.79% | -12.80% | |||
| Gross Profit | 3.71% | -19.09% | |||
| SG&A Expenses | 3.73% | -22.71% | |||
| Depreciation & Amortization | 3.77% | 4.58% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.73% | 3.09% | |||
| Operating Income | -3.73% | -5.14% | |||
| Income Before Tax | -3.73% | -8.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.73% | -8.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.73% | -8.06% | |||
| EBIT | -3.73% | -5.14% | |||
| EBITDA | -3.73% | -3.52% | |||
| EPS Basic | -4.00% | 24.24% | |||
| Normalized Basic EPS | -3.17% | 23.17% | |||
| EPS Diluted | -4.00% | 24.24% | |||
| Normalized Diluted EPS | -3.17% | 23.17% | |||
| Average Basic Shares Outstanding | 0.00% | 42.09% | |||
| Average Diluted Shares Outstanding | 0.00% | 42.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||